Andrew Webb
Förmögenhet: 944 329 $ per 2026-06-30
Förmögenhet: 944 329 $ per 2026-06-30
Mr. Andrew J.
Webb is an Executive Chairman & Chief Executive Officer at CRISM Therapeutics Corp.
and a Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd. He is on the Board of Directors at Novel Technologies Holdings Ltd. and Extruded Pharmaceuticals Ltd. Mr. Webb was previously employed as a Commercial Director by DxS Ltd., a Non-Executive Director by Arcis Biotechnology Ltd., and a Chief Executive Officer by EKF Molecular Diagnostics Ltd. He also served on the board at Convert2Green Ltd.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
9,22 % | 2025-12-31 | 7 297 190 ( 9,22 % ) | 944 329 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktör/Styrelseledamot | 2017-11-23 |
| Företag | Position | Slut |
|---|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Företagsledare/Principal | - |
EKF Molecular Diagnostics Ltd. | Verkställande Direktör | - |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Direktör/Styrelseledamot | - |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 5 |
|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Process Industries |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Health Technology |
EKF Molecular Diagnostics Ltd. | |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Välj din utgåva
All finansiell information anpassad till den nationella nivån